Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Obesity | Research article

Prevalence, awareness, treatment, and control of hypertension in Northern China: a cross-sectional study

Authors: Xiaoqian Xu, Han Bao, Zixuan Tian, Hao Zhu, Lige Zhu, Liwei Niu, Tao Yan, Hairong Dong, Xin Fang, Xingguang Zhang

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Hypertension has always been a worldwide health concern. The purpose of this study was to investigate the prevalence, awareness, treatment, and control rates of hypertension among adult residents of northern China, where people usually have a high-fat, high-salt diet and heavy alcohol consumption.

Methods

Through the Early Screening and Comprehensive Intervention Project for High Risk Groups of Cardiovascular Diseases in the Inner Mongolia of northern China, we collected data of 70,380 residents, from September 2015 to June 2017. We assessed the prevalence, awareness, treatment, and control of hypertension in the total population and sub-populations. Multivariable logistic regression analyses were used to identify the factors associated with the prevalence and control of hypertension.

Results

Among participants, only 13.4% had optimal blood pressure levels. About 55.7% (95% confidence interval (CI) = 55.3–56.1%) of the participants had hypertension. In addition, the awareness, treatment, control and control under-treatment rate of hypertension were 52.8% (95%CI = 52.3–53.3%), 43.3% (95%CI = 42.8–43.8%), 8.6% (95%CI = 8.3–8.9%) and 19.8% (95%CI = 19.2–20.4%), respectively. Multivariable logistic regression showed that older, male, Han, living in rural areas, current drinker, not married, lower educational level, lower annual income, diabetes, obesity, and dyslipidemia were more likely to be suffered from hypertension (P < 0.05). Controlled hypertension was less common in those younger, Mongol, not married, farmer, current drinker, lower educational level, obesity, diabetes, without prior CHD, and without prior CVD (P < 0.05).

Conclusion

Among populations aged 35–75 years in Northern China, more than half have hypertension, fewer than one-tenth have successfully controlled hypertension, and fewer than one-fifth of hypertension patients receiving treatment have controlled hypertension.
Literature
1.
go back to reference Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388:1659–724.CrossRef Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388:1659–724.CrossRef
2.
go back to reference Gakidou E, Afshin A, Abajobir AA, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1345–422.CrossRef Gakidou E, Afshin A, Abajobir AA, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1345–422.CrossRef
3.
go back to reference Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2224–60.CrossRef Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2224–60.CrossRef
4.
go back to reference Yin R, Yao L, Chen Y, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res. 2006;29(6):423–32.CrossRef Yin R, Yao L, Chen Y, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res. 2006;29(6):423–32.CrossRef
5.
go back to reference GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020; 396(10258): 1223–1249. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020; 396(10258): 1223–1249.
6.
go back to reference Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). The Lancet. 2017;390:2549–58.CrossRef Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). The Lancet. 2017;390:2549–58.CrossRef
7.
go back to reference Li D, Lv J, Liu F, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–44.CrossRef Li D, Lv J, Liu F, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–44.CrossRef
8.
go back to reference Li W, Gu H, Teo KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47000 people from China. J Hypertens. 2016;34:39–46.CrossRef Li W, Gu H, Teo KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47000 people from China. J Hypertens. 2016;34:39–46.CrossRef
9.
go back to reference Zhang J, Zheng Y, Guo Z, et al. The diversity of intestinal microbiota of Mongolians living in Inner Mongolia, China. Benef Microbes. 2013;4:319–28.CrossRef Zhang J, Zheng Y, Guo Z, et al. The diversity of intestinal microbiota of Mongolians living in Inner Mongolia, China. Benef Microbes. 2013;4:319–28.CrossRef
10.
go back to reference Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679–86.CrossRef Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679–86.CrossRef
11.
go back to reference Wang J, Zhang L, Wang F, et al. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27:1355–61.CrossRef Wang J, Zhang L, Wang F, et al. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27:1355–61.CrossRef
12.
go back to reference Wei Q, Sun J, Huang J, et al. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China. J Hum Hypertens. 2015;29(1):64–8.CrossRef Wei Q, Sun J, Huang J, et al. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China. J Hum Hypertens. 2015;29(1):64–8.CrossRef
13.
go back to reference Du M, Yin S, Wang P, et al. Self-reported hypertension in Northern China: a cross-sectional study of a risk prediction model and age trends. BMC Health Serv Res. 2018;18:475–85.CrossRef Du M, Yin S, Wang P, et al. Self-reported hypertension in Northern China: a cross-sectional study of a risk prediction model and age trends. BMC Health Serv Res. 2018;18:475–85.CrossRef
14.
go back to reference The Revision Committee of the Chinese Guidelines for the Prevention and Treatment of Hypertension. The 2018 revision of the Chinese Guidelines for the Prevention and Treatment of Hypertension. Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases 2019; 19(01):1–44 (in Chinese). The Revision Committee of the Chinese Guidelines for the Prevention and Treatment of Hypertension. The 2018 revision of the Chinese Guidelines for the Prevention and Treatment of Hypertension. Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases 2019; 19(01):1–44 (in Chinese).
15.
go back to reference Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. BES. 2002;15:83–96.PubMed Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. BES. 2002;15:83–96.PubMed
16.
go back to reference Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chinese Journal of Practical Internal Medicine 2018; 38(4): 292–344 (in Chinese). Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chinese Journal of Practical Internal Medicine 2018; 38(4): 292–344 (in Chinese).
17.
go back to reference Zhu J, Gao R, Zhao S, et al. Chinese guideline for the prevention and treatment of dyslipidemia in adults (2016 revision). Chin Circ J. 2016;16:15–35 ((in Chinese)). Zhu J, Gao R, Zhao S, et al. Chinese guideline for the prevention and treatment of dyslipidemia in adults (2016 revision). Chin Circ J. 2016;16:15–35 ((in Chinese)).
18.
go back to reference Lawes CM, Rodgers A, Bennett DA, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21(4):707–71620.CrossRef Lawes CM, Rodgers A, Bennett DA, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21(4):707–71620.CrossRef
19.
go back to reference Gu H, Li W, Yang J, et al. Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China. J Hum Hypertens. 2015;29:555–60.CrossRef Gu H, Li W, Yang J, et al. Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China. J Hum Hypertens. 2015;29:555–60.CrossRef
20.
go back to reference Chen X, Wei W, Zou S, et al. Trends in the prevalence of hypertension in island and coastal areas of china: a systematic review with meta-analysis. Am J Hypertens. 2014;27:1503–10.CrossRef Chen X, Wei W, Zou S, et al. Trends in the prevalence of hypertension in island and coastal areas of china: a systematic review with meta-analysis. Am J Hypertens. 2014;27:1503–10.CrossRef
21.
go back to reference Liang Y, Liu R, Du S, et al. Trends in incidence of hypertension in Chinese adults, 1991–2009: the China Health and Nutrition Survey. Int J Cardiol. 2014;175:96–101.CrossRef Liang Y, Liu R, Du S, et al. Trends in incidence of hypertension in Chinese adults, 1991–2009: the China Health and Nutrition Survey. Int J Cardiol. 2014;175:96–101.CrossRef
22.
go back to reference Boo S, Yoon YJ, Oh H. Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis. Medicine (Baltimore). 2018;97:e13713.CrossRef Boo S, Yoon YJ, Oh H. Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis. Medicine (Baltimore). 2018;97:e13713.CrossRef
23.
go back to reference Zhou B, Danaei G, Stevens GA, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet. 2019;394(10199):639–51.CrossRef Zhou B, Danaei G, Stevens GA, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet. 2019;394(10199):639–51.CrossRef
24.
go back to reference Kang SH, Kim SH, Cho JH, et al. Prevalence, awareness, treatment, and control of hypertension in Korea. Sci Rep. 2019;9:10970–8.CrossRef Kang SH, Kim SH, Cho JH, et al. Prevalence, awareness, treatment, and control of hypertension in Korea. Sci Rep. 2019;9:10970–8.CrossRef
25.
go back to reference Geldsetzer P, Manne-Goehler J, Marcus M-E, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet. 2019;394(10199):652–62.CrossRef Geldsetzer P, Manne-Goehler J, Marcus M-E, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet. 2019;394(10199):652–62.CrossRef
26.
go back to reference Zhang N, Chen Y, Li M, et al. Comprehensive evaluation of primary health care services in Inner Mongolia autonomous region. J Inner Mongolia Med Univ. 2015;37:299–301 ((in Chinese)). Zhang N, Chen Y, Li M, et al. Comprehensive evaluation of primary health care services in Inner Mongolia autonomous region. J Inner Mongolia Med Univ. 2015;37:299–301 ((in Chinese)).
27.
go back to reference Feng Y. The study of nutrition and health Statu in some poor regions at east of Inner Mongolia. Inner Mongolia: Inner Mongolia Medical University; 2015. ((in Chinese)). Feng Y. The study of nutrition and health Statu in some poor regions at east of Inner Mongolia. Inner Mongolia: Inner Mongolia Medical University; 2015. ((in Chinese)).
28.
go back to reference Global BMIMC. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet 2016; 388(10046): 776–86. Global BMIMC. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet 2016; 388(10046): 776–86.
29.
go back to reference Li G, Wang H, Wang Ke, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 2016;16(1):1–10. Li G, Wang H, Wang Ke, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 2016;16(1):1–10.
30.
go back to reference He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051–8.CrossRef He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051–8.CrossRef
31.
go back to reference Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139–85.CrossRef Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139–85.CrossRef
32.
go back to reference Hasi T, Hao L, Yang L, et al. Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study. Genet Mol Res. 2011;10(1):537–43.CrossRef Hasi T, Hao L, Yang L, et al. Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study. Genet Mol Res. 2011;10(1):537–43.CrossRef
33.
go back to reference Chang PY, Zhao LG, Su XL. Association of TSC gene variants and hypertension in Mongolian and Han populations. Genet Mol Res. 2011;10(2):902–9.CrossRef Chang PY, Zhao LG, Su XL. Association of TSC gene variants and hypertension in Mongolian and Han populations. Genet Mol Res. 2011;10(2):902–9.CrossRef
34.
go back to reference Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38(5):1112–27.CrossRef Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38(5):1112–27.CrossRef
35.
go back to reference Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164-4180.CrossRef Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164-4180.CrossRef
36.
go back to reference Wang S. Cross-sectional study on chronic disease and risk factors among adult residents in Jilin Province. Jilin: Jilin University; 2015. ((in Chinese)). Wang S. Cross-sectional study on chronic disease and risk factors among adult residents in Jilin Province. Jilin: Jilin University; 2015. ((in Chinese)).
37.
go back to reference Grotto I, Huerta M, Sharabi Y. Hypertension and socioeconomic status. Curr Opin Cardiol. 2008;23:335–9.CrossRef Grotto I, Huerta M, Sharabi Y. Hypertension and socioeconomic status. Curr Opin Cardiol. 2008;23:335–9.CrossRef
38.
go back to reference Bozza R, Campos W, Barbosa Filho VC, et al. High blood pressure in adolescents of Curitiba: prevalence and associated factors. Arq Bras Cardiol. 2016;106(5):411–8.PubMedPubMedCentral Bozza R, Campos W, Barbosa Filho VC, et al. High blood pressure in adolescents of Curitiba: prevalence and associated factors. Arq Bras Cardiol. 2016;106(5):411–8.PubMedPubMedCentral
39.
go back to reference Khanam MA, Lindeboom W, Razzaque A, et al. Prevalence and determinants of pre-hypertension and hypertension among the adults in rural Bangladesh: findings from a community-based study. BMC Public Health. 2015;15:203–12.CrossRef Khanam MA, Lindeboom W, Razzaque A, et al. Prevalence and determinants of pre-hypertension and hypertension among the adults in rural Bangladesh: findings from a community-based study. BMC Public Health. 2015;15:203–12.CrossRef
40.
go back to reference Vigna-Taglianti F, Vadrucci S, Faggiano F, et al. Is universal prevention against youths’ substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial. J Epidemiol Commun Health. 2009;63:722–8.CrossRef Vigna-Taglianti F, Vadrucci S, Faggiano F, et al. Is universal prevention against youths’ substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial. J Epidemiol Commun Health. 2009;63:722–8.CrossRef
Metadata
Title
Prevalence, awareness, treatment, and control of hypertension in Northern China: a cross-sectional study
Authors
Xiaoqian Xu
Han Bao
Zixuan Tian
Hao Zhu
Lige Zhu
Liwei Niu
Tao Yan
Hairong Dong
Xin Fang
Xingguang Zhang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02333-7

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue